Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Lokivetmab is dosed at 1–2 mg/kg SC q30d in dogs, per Plumb's Veterinary Drug Handbook, 9th Ed — Lokivetmab, Dosages: DOGS (corpus pp.799-800); corroborated by BSAVA Small Animal Formulary 10th Ed Part A, Lokivetmab, DOSES, 'Dogs: 1 mg/kg s.c. monthly' (corpus p.250 / printed p.234). Lokivetmab is used in dogs for Canine atopic dermatitis (pruritus control). Routes documented in dogs: SC. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Lokivetmab in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Cytopoint
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| SC | 1–2 mg/kg | q30d | Monthly injection | Canine atopic dermatitis (pruritus control) | Strong | Plumb's Veterinary Drug Handbook, 9th Ed — Lokivetmab, Dosages: DOGS (corpus pp.799-800); corroborated by BSAVA Small Animal Formulary 10th Ed Part A, Lokivetmab, DOSES, 'Dogs: 1 mg/kg s.c. monthly' (corpus p.250 / printed p.234) |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Caninized monoclonal antibody that specifically targets and neutralizes IL-31, the primary pruritogenic cytokine in canine atopic dermatitis.
Dogs only. Monthly SC injection. Very safe profile (biological, not chemical immunosuppression). Minimal drug interactions. Some dogs may not respond. Not immunosuppressive in the traditional sense.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Lokivetmab dose range in dogs, with cited source references: SC 1–2 mg/kg q30d. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Lokivetmab in dogs: SC.
Cited course lengths for Lokivetmab in dogs include: Monthly injection. Duration depends on the indication — match it to the specific dose rule in the table above.
Lokivetmab is indicated in dogs for: Canine atopic dermatitis (pruritus control).
These are general warnings for Lokivetmab across species; consult the dog dosing table above for species-specific guidance. Dogs only. Monthly SC injection. Very safe profile (biological, not chemical immunosuppression). Minimal drug interactions. Some dogs may not respond. Not immunosuppressive in the traditional sense.
Why a species-specific page? Lokivetmab pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.